ArticleJournal for immunotherapy of cancer2024

TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment.

Fadi Azar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.